alexa Dmitri V. Krysko | OMICS International | VIB-Ghent Univ
ISSN: 2155-983X

Journal of Nanomedicine & Biotherapeutic Discovery
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Dmitri V. Krysko
Dmitri V. Krysko Dmitri V. Krysko
Molecular Signalling and Cell Death Unit
Department for Molecular Biomedical Research (DMBR)
VIB-Ghent University, Belgium
Tel. 32-9-331-37-23
Fax: 32-9-331-36-09

Dmitri V. Krysko graduated with greatest distinction from Saratov State Medical University in Russia in 1998. In 2000 he moved to Belgium, where in 2006 he obtained a Ph.D. degree in Medical and Health Sciences from Ghent University. In 2006 he became a laureate of the Annual Belgian Society for Microscopy Award in Life Sciences for the “Outstanding PhD thesis”. Dr Krysko then obtained a postdoctoral scholarship from The Research Foundation-Flanders (FWO, Belgium). He is currently working as a senior FWO postdoctoral scientist in the Molecular Signalling and Cell Death Unit at the Department for Molecular Biomedical Research in VIB-Ghent University (Belgium). Dr Krysko is leading a subgroup investigating how dying cells (apoptotic, necrotic and autophagic) interact with innate and adaptive immune system by means of Damage-Asscociated Molecular Patterns (DAMPs).Dr Krysko is an Editorial Board Member of “Apoptosis: An International Journal on Programmed Cell Death,Mediators of Inflammation and “Frontiers in Molecular Innate Immunity” Dr. Krysko was a co-quest editor of a special issue of Apoptosis (“Clearance of dead cells: mechanisms, immune responses and implication in the development of diseases;” 2010; 15; 995-1164) and a co-editor of a book (“Phagocytosis of dying cells: from molecular mechanisms to human diseases;2009 Springer.

Research Interest

The major scientific interest of Dr. Dmitri V. Krysko is a comparative analysis of how cells dying by different cell death modalities (apoptotic, necrotic and autophagic) interact with innate and adaptive immune system by means of damage-associated molecular patterns (DAMP).


Global Speakers in the subject

Global Experts in the subject

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version